Synopsis
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Chewable & Orodispersible Aids
Taste Masking
Direct Compression
Co-Processed Excipients
Parenteral
Disintegrants & Superdisintegrants
Granulation
API Stability Enhancers
Thickeners and Stabilizers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Pamidronate Disodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pamidronate Disodium , including repackagers and relabelers. The FDA regulates Pamidronate Disodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pamidronate Disodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pamidronate Disodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pamidronate Disodium supplier is an individual or a company that provides Pamidronate Disodium active pharmaceutical ingredient (API) or Pamidronate Disodium finished formulations upon request. The Pamidronate Disodium suppliers may include Pamidronate Disodium API manufacturers, exporters, distributors and traders.
click here to find a list of Pamidronate Disodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pamidronate Disodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Pamidronate Disodium active pharmaceutical ingredient (API) in detail. Different forms of Pamidronate Disodium DMFs exist exist since differing nations have different regulations, such as Pamidronate Disodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pamidronate Disodium DMF submitted to regulatory agencies in the US is known as a USDMF. Pamidronate Disodium USDMF includes data on Pamidronate Disodium 's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pamidronate Disodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pamidronate Disodium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Pamidronate Disodium Drug Master File in Japan (Pamidronate Disodium JDMF) empowers Pamidronate Disodium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Pamidronate Disodium JDMF during the approval evaluation for pharmaceutical products. At the time of Pamidronate Disodium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Pamidronate Disodium suppliers with JDMF on PharmaCompass.
A Pamidronate Disodium CEP of the European Pharmacopoeia monograph is often referred to as a Pamidronate Disodium Certificate of Suitability (COS). The purpose of a Pamidronate Disodium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Pamidronate Disodium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Pamidronate Disodium to their clients by showing that a Pamidronate Disodium CEP has been issued for it. The manufacturer submits a Pamidronate Disodium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Pamidronate Disodium CEP holder for the record. Additionally, the data presented in the Pamidronate Disodium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Pamidronate Disodium DMF.
A Pamidronate Disodium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Pamidronate Disodium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Pamidronate Disodium suppliers with CEP (COS) on PharmaCompass.
A Pamidronate Disodium written confirmation (Pamidronate Disodium WC) is an official document issued by a regulatory agency to a Pamidronate Disodium manufacturer, verifying that the manufacturing facility of a Pamidronate Disodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Pamidronate Disodium APIs or Pamidronate Disodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Pamidronate Disodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Pamidronate Disodium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pamidronate Disodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pamidronate Disodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pamidronate Disodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pamidronate Disodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pamidronate Disodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pamidronate Disodium suppliers with NDC on PharmaCompass.
Pamidronate Disodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pamidronate Disodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pamidronate Disodium GMP manufacturer or Pamidronate Disodium GMP API supplier for your needs.
A Pamidronate Disodium CoA (Certificate of Analysis) is a formal document that attests to Pamidronate Disodium 's compliance with Pamidronate Disodium specifications and serves as a tool for batch-level quality control.
Pamidronate Disodium CoA mostly includes findings from lab analyses of a specific batch. For each Pamidronate Disodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pamidronate Disodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Pamidronate Disodium EP), Pamidronate Disodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pamidronate Disodium USP).
LOOKING FOR A SUPPLIER?
